Suppr超能文献

KIR3DL1/S1 和 KIR2DL2/L3 变异在 H1N1/09 ICU 患者中的富集:一项探索性研究。

Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.

机构信息

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

出版信息

PLoS One. 2011;6(12):e29200. doi: 10.1371/journal.pone.0029200. Epub 2011 Dec 28.

Abstract

BACKGROUND

Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobulin-like receptors (KIR) and HLA class I ligand interactions. To study factors involved in NK cell dysfunction in overactive immune responses to H1N1 infection, KIR3DL1/S1 and KIR2DL2/L3 allotypes and cognate HLA ligands of H1N1/09 intensive-care unit (ICU) patients were determined.

METHODOLOGY AND FINDINGS

KIR3DL1/S1, KIR2DL2/L3, and HLA -B and -C of 51 H1N1/09 ICU patients and 105 H1N1-negative subjects (St. Theresa Point, Manitoba) were characterized. We detected an increase of 3DL1 ligand-negative pairs (3DL1/S1(+) Bw6(+) Bw4(-)), and a lack of 2DL1 HLA-C2 ligands, among ICU patients. They were also significantly enriched for 2DL2/L3 ligand-positive pairs (P<0.001, Pc<0.001; Odds Ratio:6.3158, CI95%:2.481-16.078). Relative to St. Theresa aboriginals (STh) and Venezuelan Amerindians (VA), allotypes enriched among aboriginal ICU patients (Ab) were: 2DL3 (Ab>VA, P=0.024, Pc=0.047; Odds Ratio:2.563, CI95%:1.109-5.923), 3DL100101 (Ab>VA, P<0.001, Pc<0.001), 3DL1*01502 (Ab>STh, P=0.034, Pc=0.268), and 3DL1029 (Ab>STh, P=0.039, Pc=0.301). Aboriginal patients ligand-positive for 3DL1/S1 and 2DL1 had the lowest probabilities of death (R(d)) (R(d)=28%), compared to patients that were 3DL1/S1 ligand-negative (R(d)=52%) or carried 3DL1029 (R(d)=52%). Relative to Caucasoids (CA), two allotypes were enriched among non-aboriginal ICU patients (NAb): 3DL100401 (NAb>CA, P<0.001, Pc<0.001) and 3DL101502 (CA<NAb, P=0.012, Pc=0.156). Non-aboriginal patients with ligands for all three KIRs (3DL1/S1, 2DL2/L3, and 2DL1) had the lowest probabilities of death (R(d)=36%), compared to subjects with 3DL101502 (R(d)=48%) and/or 3DL1*00401 (R(d)=58%).

CONCLUSIONS

Specific KIR3DL1/S1 allotypes, 3DL1/S1 and 2DL1 ligand-negative pairs, and 2DL2/L3 ligand-positive pairs were enriched among ICU patients. This suggests a possible association with NK cell dysfunction in patients with overactive immune responses to H1N1/09, leading to severe disease.

摘要

背景

大流行性甲型流感(H1N1/09)病毒的感染导致全球特定族群出现明显的病理变化。自然杀伤(NK)细胞在对病毒感染的早期先天免疫反应中非常重要。NK 细胞的激活在一定程度上取决于杀伤细胞免疫球蛋白样受体(KIR)和 HLA Ⅰ类配体的相互作用。为了研究在甲型 H1N1/09 感染过度活跃的免疫反应中导致 NK 细胞功能障碍的因素,确定了甲型 H1N1/09 重症监护病房(ICU)患者的 KIR3DL1/S1 和 KIR2DL2/L3 同种型和相应的 HLA 配体。

方法和结果

对 51 例甲型 H1N1/09 ICU 患者和 105 例甲型 H1N1 阴性对照者(曼尼托巴圣特蕾莎角)的 KIR3DL1/S1、KIR2DL2/L3 和 HLA-B 和-C 进行了特征描述。我们检测到 ICU 患者中 3DL1 配体阴性对(3DL1/S1(+) Bw6(+) Bw4(-))增加,以及缺乏 2DL1 HLA-C2 配体。他们也显著富含 2DL2/L3 配体阳性对(P<0.001,Pc<0.001;优势比:6.3158,95%置信区间:2.481-16.078)。与圣特蕾莎原住民(STh)和委内瑞拉美洲原住民(VA)相比,在原住民 ICU 患者中富集的同种型为:2DL3(Ab>VA,P=0.024,Pc=0.047;优势比:2.563,95%置信区间:1.109-5.923)、3DL100101(Ab>VA,P<0.001,Pc<0.001)、3DL1*01502(Ab>STh,P=0.034,Pc=0.268)和 3DL1029(Ab>STh,P=0.039,Pc=0.301)。3DL1/S1 和 2DL1 配体阳性的原住民患者的死亡概率(R(d))最低(R(d)=28%),而 3DL1/S1 配体阴性的患者(R(d)=52%)或携带 3DL1029 的患者(R(d)=52%)的死亡概率则较高。与白种人(CA)相比,在非原住民 ICU 患者(NAb)中富集了两种同种型:3DL100401(NAb>CA,P<0.001,Pc<0.001)和 3DL101502(CA<NAb,P=0.012,Pc=0.156)。三种 KIR(3DL1/S1、2DL2/L3 和 2DL1)配体均为阳性的非原住民患者的死亡概率最低(R(d)=36%),而 3DL101502(R(d)=48%)和/或 3DL1*00401(R(d)=58%)的患者则较高。

结论

ICU 患者中富集了特定的 KIR3DL1/S1 同种型、3DL1/S1 和 2DL1 配体阴性对以及 2DL2/L3 配体阳性对。这表明在甲型 H1N1/09 感染过度活跃的免疫反应中 NK 细胞功能障碍可能与严重疾病有关。

相似文献

引用本文的文献

本文引用的文献

4
The IMGT/HLA database.国际免疫遗传学信息系统/人类白细胞抗原数据库
Nucleic Acids Res. 2011 Jan;39(Database issue):D1171-6. doi: 10.1093/nar/gkq998. Epub 2010 Nov 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验